| Tocilizumab and COVID-19: timing of administration and efficacy E Abidi, WS El Nekidy, E Alefishat, N Rahman, GA Petroianu, ... Frontiers in pharmacology 13, 825749, 2022 | 47 | 2022 |
| Thromboelastography findings in critically ill COVID-19 patients N Salem, B Atallah, WS El Nekidy, ZG Sadik, WM Park, J Mallat Journal of Thrombosis and Thrombolysis 51 (4), 961-965, 2021 | 40 | 2021 |
| The impact of protocol‐based high‐intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID‐19 patients B Atallah, ZG Sadik, N Salem, WS El Nekidy, W Almahmeed, WM Park, ... Anaesthesia 76 (3), 327-335, 2021 | 35 | 2021 |
| Factors influencing vancomycin loading dose for hospitalized hemodialysis patients: prospective observational cohort study WS El Nekidy, MM El-Masri, GS Umstead, M Dehoorne-Smith The Canadian Journal of Hospital Pharmacy 65 (6), 436, 2012 | 26 | 2012 |
| Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers B Atallah, W El Nekidy, SI Mallah, A Cherfan, L AbdelWareth, J Mallat, ... Thrombosis Journal 18, 1-6, 2020 | 24 | 2020 |
| Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient WS El Nekidy, MY Mooty, N Attallah, L Cardona, MF Bonilla, IM Ghazi IDCases 9, 53-55, 2017 | 19 | 2017 |
| Risk factors for recurrence of Clostridioides difficile in hospitalized patients D Alrahmany, BJ Ereshefsky, WS El Nekidy, G Harb, L Pontiggia, ... Journal of Infection and Public Health 14 (11), 1642-1649, 2021 | 15 | 2021 |
| Predicting maintenance doses of vancomycin for hospitalized patients undergoing hemodialysis WS El Nekidy, MM El-Masri, GS Umstead, M Dehoorne-Smith The Canadian Journal of Hospital Pharmacy 69 (5), 341, 2016 | 15 | 2016 |
| Acinetobacter baumannii Infections in Hospitalized Patients, Treatment Outcomes D Alrahmany, AF Omar, G Harb, WS El Nekidy, IM Ghazi Antibiotics 10 (6), 630, 2021 | 14 | 2021 |
| Salvage of hemodialysis catheter in staphylococcal bacteremia: case series, revisiting the literature, and the role of the pharmacist WS El Nekidy, D Soong, A Kadri, O Tabbara, A Ibrahim, IM Ghazi Case Reports in Nephrology and Dialysis 8 (2), 121-129, 2018 | 14 | 2018 |
| Comparison of alteplase (tissue plasminogen activator) high‐dose vs. low‐dose protocol in restoring hemodialysis catheter function: The ALTE‐DOSE study O Yaseen, MM El‐Masri, WS El Nekidy, D Soong, M Ibrahim, JW Speirs, ... Hemodialysis International 17 (3), 434-440, 2013 | 13 | 2013 |
| Ertapenem neurotoxicity in hemodialysis patients—safe and effective dosing is still needed: a retrospective study and literature review WS El Nekidy, H Elrefaei, TJL St. John, NM Attallah, F Kablaoui, A Nusair, ... Annals of Pharmacotherapy 55 (1), 52-58, 2021 | 12 | 2021 |
| Treatment of recurrent urinary tract infections in anuric hemodialysis patient, do we really need antimicrobial urinary concentration? WS El Nekidy, D Soong, M Mooty, IM Ghazi IDCases 20, e00748, 2020 | 12 | 2020 |
| Appropriateness of the direct oral anticoagulants dosing in the Middle East Gulf Region Z Anouassi, B Atallah, LO Alsoud, W El Nekidy, W Al Mahmeed, ... Journal of Cardiovascular Pharmacology 77 (2), 182-188, 2021 | 9 | 2021 |
| Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach IM Ghazi, WS El Nekidy, R Asay, P Fingmori, A Knarr, M Awad PLoS One 15 (5), e0233335, 2020 | 9 | 2020 |
| Pharmacy practice standards for outpatient nephrology settings KE Cardone, R Maxson, KH Cho, JM Davis, WS El Nekidy, SL Kane-Gill, ... Kidney Medicine 4 (8), 100509, 2022 | 7 | 2022 |
| Comprehensive approach to reduce surgical site infections in patients undergoing neurosurgical procedures AR Nusair, WS El Nekidy, L Reynolds, D Evans, R El-Lababidi, A Alatoom Surgical Infections 22 (2), 217-221, 2021 | 7 | 2021 |
| Y-site administration of imipenem/cilastatin/relebactam with common intravenous medications AS Mr, AD Ms, RP Ms, KP Ms, PL Ms Clinical Therapeutics 42 (3), 475-485, 2020 | 7 | 2020 |
| Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID‐19‐Associated Pneumonia and Acute Respiratory Distress Syndrome S Gupta, R Madhyastha, F Hamed, M Balkis, W El Nekidy, N Attallah Case reports in nephrology 2020 (1), 8829309, 2020 | 6 | 2020 |
| Factors predicting vancomycin therapy outcomes in hemodialysis outpatients and the role of the nephrology stewardship pharmacist WS El Nekidy, MM El‐Masri, IM Ghazi, D Soong Hemodialysis International 23 (4), 449-457, 2019 | 6 | 2019 |
Islam M. GhaziLong Island University在 liu.edu 的电子邮件经过验证
